REVOLUTION MEDICINES INC (RVMD) Stock Price, Quote, News and Overview
NASDAQ:RVMD - Nasdaq - US76155X1000 - Common Stock - Currency: USD
RVMD Quote, Performance and Key Statistics
REVOLUTION MEDICINES INC
NASDAQ:RVMD (1/24/2025, 5:20:02 PM)
After market: 40.99 0 (0%)40.99
-0.15 (-0.36%)
The current stock price of RVMD is 40.99 USD. In the past month the price decreased by -6.69%. In the past year, price increased by 47.71%.
RVMD Latest News, Press Releases and Analysis
Revolution Medicines to Present at 43rd Annual J.P. Morgan Healthcare Conference
REDWOOD CITY, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel...
Revolution Medicines (RVMD) Shares Cross Below 200 DMA
Revolution Medicines Becomes Oversold (RVMD)
Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares
Underwriters’ full exercise of option brings gross proceeds to $862.5 million...
Revolution Medicines Announces Pricing of Upsized $750.0 Million Public Offering of Common Stock and Pre-Funded Warrants
REDWOOD CITY, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted...
RVMD Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.84 | 300.94B | ||
| AMGN | AMGEN INC | 14.33 | 148.05B | ||
| GILD | GILEAD SCIENCES INC | 21.01 | 115.99B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 862 | 113.22B | ||
| REGN | REGENERON PHARMACEUTICALS | 14.88 | 74.26B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.80B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.95B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.47B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.64B | ||
| NTRA | NATERA INC | N/A | 22.13B | ||
| BIIB | BIOGEN INC | 8.95 | 21.30B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.52B |
Related stock screener links
About RVMD
Company Profile
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. The company is headquartered in Redwood City, California and currently employs 490 full-time employees. The company went IPO on 2020-02-13. The Company’s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which it refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target key nodes in the RAS pathway or associated pathways, which it refers to as RAS Companion Inhibitors. Its RAS(ON) Inhibitors are designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or in combination with RAS Companion Inhibitors or other therapeutic agents. Its RAS Companion Inhibitors are designed primarily for combination treatment strategies centered on its RAS(ON) Inhibitors. The Company’s RAS(ON) Inhibitors RMC-6236 RMC-6291 and RMC-9805 are in clinical development. RMC-6236, its RASMULTI(ON) inhibitor, is designed as a potent, oral, RAS-selective tri-complex inhibitor of multiple RAS(ON) variants, including cancer drivers.
Company Info
REVOLUTION MEDICINES INC
700 Saginaw Dr
Redwood City CALIFORNIA 94063 US
CEO: Mark A. Goldsmith
Employees: 443
Company Website: https://www.revmed.com/
Investor Relations: https://ir.revmed.com/
Phone: 14157663638
RVMD FAQ
What is the stock price of RVMD?
The current stock price of RVMD is 40.99 USD.
What is the symbol for REVOLUTION MEDICINES INC stock?
The exchange symbol of REVOLUTION MEDICINES INC is RVMD and it is listed on the Nasdaq exchange.
On which exchange is RVMD stock listed?
RVMD stock is listed on the Nasdaq exchange.
Is RVMD a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for RVMD, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of RVMD.
Does RVMD stock pay dividends?
RVMD does not pay a dividend.
What is the Price/Earnings (PE) ratio of RVMD?
RVMD does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.59).
What is the Short Interest ratio of RVMD stock?
The outstanding short interest for RVMD is 9.06% of its float.
RVMD Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to RVMD. When comparing the yearly performance of all stocks, RVMD is one of the better performing stocks in the market, outperforming 79.14% of all stocks.
RVMD Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to RVMD. RVMD has a great financial health rating, but its profitability evaluates not so good.
RVMD Financial Highlights
Over the last trailing twelve months RVMD reported a non-GAAP Earnings per Share(EPS) of -3.59. The EPS decreased by -10.02% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -32.16% | ||
| ROE | -36.2% | ||
| Debt/Equity | 0 |
RVMD Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 89% to RVMD. The Buy consensus is the average rating of analysts ratings from 21 analysts.
For the next year, analysts expect an EPS growth of 5.94% and a revenue growth -97.31% for RVMD